TWC
QNTM

TD Waterhouse Canada’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

TD Waterhouse Canada’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20 Sell
6
-14
-70% -$66 ﹤0.01% 2372
2026
Q1 		$88 Buy
+20
New +$90 ﹤0.01% 2226
2025
Q4 		– Sell
-2
Closed -$33 – 2190
2025
Q3 		$33 Sell
2
-1
-33% -$20 ﹤0.01% 2026
2025
Q2 		$57 Buy
3
+1
+50% +$12 ﹤0.01% 1934
2025
Q1 		$16 Hold
2
– – ﹤0.01% 1920
2024
Q4 		$7 Sell
2
-1
-33% -$5 ﹤0.01% 1952
2024
Q3 		$11 Sell
3
-5
-63% -$31 ﹤0.01% 1881
2024
Q2 		$74 Buy
+8
New +$195 ﹤0.01% 1846
2024
Q1 		– Sell
-160
Closed -$9.59K – 1968
2023
Q4 		$9.59K Sell
160
-1
-0.6% -$70 ﹤0.01% 1261
2023
Q3 		$12.3K Hold
161
– – ﹤0.01% 1185
2023
Q2 		$12K Hold
161
– – ﹤0.01% 1208
2023
Q1 		$16.4K Buy
161
+154
+2,200% +$13.2K ﹤0.01% 1128
2022
Q4 		$501 Hold
7
– – ﹤0.01% 1611
2022
Q3 		$533 Sell
7
-2
-22% -$117 ﹤0.01% 1623
2022
Q2 		$550 Buy
9
+2
+29% +$120 ﹤0.01% 1663
2022
Q1 		$523 Buy
7
+1
+17% +$61 ﹤0.01% 1704
2021
Q4 		$518 Buy
+6
New +$521 ﹤0.01% 1683

Other funds holding QNTM

PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Waterhouse Canada's QNTM Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 70% in Q2 2026, selling an estimated $66 and leaving 6 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

TD Waterhouse Canada first reported a position in QNTM in Q4 2021 and has held it in 17 quarters since. The position peaked at $16.4K in Q1 2023. 8 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

  • TD Waterhouse Canada held 6 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $20 as of Q2 2026.
  • TD Waterhouse Canada sold 14 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2026, an estimated $66.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2372 holding.
  • TD Waterhouse Canada first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2021 and has held it in 17 quarters since.
  • TD Waterhouse Canada's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $16.4K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.